Covid-19 Impact on Global Transcriptomics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transcriptomics Revenue
1.4 Market Analysis by Type
1.4.1 Global Transcriptomics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 PCR
1.4.3 Microarray
1.4.4 Sequencing
1.5 Market by Application
1.5.1 Global Transcriptomics Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical and Biotechnology
1.5.3 Academic Research and Government Institutes
1.5.4 Hospitals and Diagnostic Centers
1.6 Coronavirus Disease 2019 (Covid-19): Transcriptomics Industry Impact
1.6.1 How the Covid-19 is Affecting the Transcriptomics Industry
1.6.1.1 Transcriptomics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Transcriptomics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Transcriptomics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Transcriptomics Market Perspective (2015-2026)
2.2 Transcriptomics Growth Trends by Regions
2.2.1 Transcriptomics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Transcriptomics Historic Market Share by Regions (2015-2020)
2.2.3 Transcriptomics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Transcriptomics Market Growth Strategy
2.3.6 Primary Interviews with Key Transcriptomics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Transcriptomics Players by Market Size
3.1.1 Global Top Transcriptomics Players by Revenue (2015-2020)
3.1.2 Global Transcriptomics Revenue Market Share by Players (2015-2020)
3.1.3 Global Transcriptomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Transcriptomics Market Concentration Ratio
3.2.1 Global Transcriptomics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Transcriptomics Revenue in 2019
3.3 Transcriptomics Key Players Head office and Area Served
3.4 Key Players Transcriptomics Product Solution and Service
3.5 Date of Enter into Transcriptomics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Transcriptomics Historic Market Size by Type (2015-2020)
4.2 Global Transcriptomics Forecasted Market Size by Type (2021-2026)
5 Transcriptomics Breakdown Data by Application (2015-2026)
5.1 Global Transcriptomics Market Size by Application (2015-2020)
5.2 Global Transcriptomics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Transcriptomics Market Size (2015-2020)
6.2 Transcriptomics Key Players in North America (2019-2020)
6.3 North America Transcriptomics Market Size by Type (2015-2020)
6.4 North America Transcriptomics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Transcriptomics Market Size (2015-2020)
7.2 Transcriptomics Key Players in Europe (2019-2020)
7.3 Europe Transcriptomics Market Size by Type (2015-2020)
7.4 Europe Transcriptomics Market Size by Application (2015-2020)
8 China
8.1 China Transcriptomics Market Size (2015-2020)
8.2 Transcriptomics Key Players in China (2019-2020)
8.3 China Transcriptomics Market Size by Type (2015-2020)
8.4 China Transcriptomics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Transcriptomics Market Size (2015-2020)
9.2 Transcriptomics Key Players in Japan (2019-2020)
9.3 Japan Transcriptomics Market Size by Type (2015-2020)
9.4 Japan Transcriptomics Market Size by Application (2015-2020)
10 Key Players Profiles
10.1 Thermo Fisher Scientific
10.1.1 Thermo Fisher Scientific Company Details
10.1.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
10.1.3 Thermo Fisher Scientific Transcriptomics Introduction
10.1.4 Thermo Fisher Scientific Revenue in Transcriptomics Business (2015-2020))
10.1.5 Thermo Fisher Scientific Recent Development
10.2 Illumina
10.2.1 Illumina Company Details
10.2.2 Illumina Business Overview and Its Total Revenue
10.2.3 Illumina Transcriptomics Introduction
10.2.4 Illumina Revenue in Transcriptomics Business (2015-2020)
10.2.5 Illumina Recent Development
10.3 QIAGEN (Exiqon)
10.3.1 QIAGEN (Exiqon) Company Details
10.3.2 QIAGEN (Exiqon) Business Overview and Its Total Revenue
10.3.3 QIAGEN (Exiqon) Transcriptomics Introduction
10.3.4 QIAGEN (Exiqon) Revenue in Transcriptomics Business (2015-2020)
10.3.5 QIAGEN (Exiqon) Recent Development
10.4 Agilent Technologies
10.4.1 Agilent Technologies Company Details
10.4.2 Agilent Technologies Business Overview and Its Total Revenue
10.4.3 Agilent Technologies Transcriptomics Introduction
10.4.4 Agilent Technologies Revenue in Transcriptomics Business (2015-2020)
10.4.5 Agilent Technologies Recent Development
10.5 Roche
10.5.1 Roche Company Details
10.5.2 Roche Business Overview and Its Total Revenue
10.5.3 Roche Transcriptomics Introduction
10.5.4 Roche Revenue in Transcriptomics Business (2015-2020)
10.5.5 Roche Recent Development
10.6 GE Healthcare
10.6.1 GE Healthcare Company Details
10.6.2 GE Healthcare Business Overview and Its Total Revenue
10.6.3 GE Healthcare Transcriptomics Introduction
10.6.4 GE Healthcare Revenue in Transcriptomics Business (2015-2020)
10.6.5 GE Healthcare Recent Development
10.7 Bio-Rad Laboratories
10.7.1 Bio-Rad Laboratories Company Details
10.7.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
10.7.3 Bio-Rad Laboratories Transcriptomics Introduction
10.7.4 Bio-Rad Laboratories Revenue in Transcriptomics Business (2015-2020)
10.7.5 Bio-Rad Laboratories Recent Development
10.8 Fluidigm
10.8.1 Fluidigm Company Details
10.8.2 Fluidigm Business Overview and Its Total Revenue
10.8.3 Fluidigm Transcriptomics Introduction
10.8.4 Fluidigm Revenue in Transcriptomics Business (2015-2020)
10.8.5 Fluidigm Recent Development
11 Analyst's Viewpoints/Conclusions
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
List of TablesTable 1. Transcriptomics Key Market Segments
Table 2. Key Players Covered: Ranking by Transcriptomics Revenue
Table 3. Ranking of Global Top Transcriptomics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Transcriptomics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of PCR
Table 6. Key Players of Microarray
Table 7. Key Players of Sequencing
Table 8. COVID-19 Impact Global Market: (Four Transcriptomics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Transcriptomics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Transcriptomics Players to Combat Covid-19 Impact
Table 13. Global Transcriptomics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Transcriptomics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Transcriptomics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Transcriptomics Market Share by Regions (2015-2020)
Table 17. Global Transcriptomics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Transcriptomics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Transcriptomics Market Growth Strategy
Table 23. Main Points Interviewed from Key Transcriptomics Players
Table 24. Global Transcriptomics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Transcriptomics Market Share by Players (2015-2020)
Table 26. Global Top Transcriptomics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transcriptomics as of 2019)
Table 27. Global Transcriptomics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Transcriptomics Product Solution and Service
Table 30. Date of Enter into Transcriptomics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Transcriptomics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Transcriptomics Market Size Share by Type (2015-2020)
Table 34. Global Transcriptomics Revenue Market Share by Type (2021-2026)
Table 35. Global Transcriptomics Market Size Share by Application (2015-2020)
Table 36. Global Transcriptomics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Transcriptomics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Transcriptomics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Transcriptomics Market Share (2019-2020)
Table 40. North America Transcriptomics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Transcriptomics Market Share by Type (2015-2020)
Table 42. North America Transcriptomics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Transcriptomics Market Share by Application (2015-2020)
Table 44. Europe Key Players Transcriptomics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Transcriptomics Market Share (2019-2020)
Table 46. Europe Transcriptomics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Transcriptomics Market Share by Type (2015-2020)
Table 48. Europe Transcriptomics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Transcriptomics Market Share by Application (2015-2020)
Table 50. China Key Players Transcriptomics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Transcriptomics Market Share (2019-2020)
Table 52. China Transcriptomics Market Size by Type (2015-2020) (Million US$)
Table 53. China Transcriptomics Market Share by Type (2015-2020)
Table 54. China Transcriptomics Market Size by Application (2015-2020) (Million US$)
Table 55. China Transcriptomics Market Share by Application (2015-2020)
Table 56. Japan Key Players Transcriptomics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Transcriptomics Market Share (2019-2020)
Table 58. Japan Transcriptomics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Transcriptomics Market Share by Type (2015-2020)
Table 60. Japan Transcriptomics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Transcriptomics Market Share by Application (2015-2020)
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Product
Table 65. Thermo Fisher Scientific Revenue in Transcriptomics Business (2015-2020) (Million US$)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. Illumina Company Details
Table 68. Illumina Business Overview
Table 69. Illumina Product
Table 70. Illumina Revenue in Transcriptomics Business (2015-2020) (Million US$)
Table 71. Illumina Recent Development
Table 72. QIAGEN (Exiqon) Company Details
Table 73. QIAGEN (Exiqon) Business Overview
Table 74. QIAGEN (Exiqon) Product
Table 75. QIAGEN (Exiqon) Revenue in Transcriptomics Business (2015-2020) (Million US$)
Table 76. QIAGEN (Exiqon) Recent Development
Table 77. Agilent Technologies Company Details
Table 78. Agilent Technologies Business Overview
Table 79. Agilent Technologies Product
Table 80. Agilent Technologies Revenue in Transcriptomics Business (2015-2020) (Million US$)
Table 81. Agilent Technologies Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Product
Table 85. Roche Revenue in Transcriptomics Business (2015-2020) (Million US$)
Table 86. Roche Recent Development
Table 87. GE Healthcare Company Details
Table 88. GE Healthcare Business Overview
Table 89. GE Healthcare Product
Table 90. GE Healthcare Revenue in Transcriptomics Business (2015-2020) (Million US$)
Table 91. GE Healthcare Recent Development
Table 92. Bio-Rad Laboratories Company Details
Table 93. Bio-Rad Laboratories Business Overview
Table 94. Bio-Rad Laboratories Product
Table 95. Bio-Rad Laboratories Revenue in Transcriptomics Business (2015-2020) (Million US$)
Table 96. Bio-Rad Laboratories Recent Development
Table 97. Fluidigm Business Overview
Table 98. Fluidigm Product
Table 99. Fluidigm Company Details
Table 100. Fluidigm Revenue in Transcriptomics Business (2015-2020) (Million US$)
Table 101. Fluidigm Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Transcriptomics Market Share by Type: 2020 VS 2026
Figure 2. PCR Features
Figure 3. Microarray Features
Figure 4. Sequencing Features
Figure 5. Global Transcriptomics Market Share by Application: 2020 VS 2026
Figure 6. Pharmaceutical and Biotechnology Case Studies
Figure 7. Academic Research and Government Institutes Case Studies
Figure 8. Hospitals and Diagnostic Centers Case Studies
Figure 9. Transcriptomics Report Years Considered
Figure 10. Global Transcriptomics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Transcriptomics Market Share by Regions: 2020 VS 2026
Figure 12. Global Transcriptomics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Transcriptomics Market Share by Players in 2019
Figure 15. Global Top Transcriptomics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transcriptomics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Transcriptomics Revenue in 2019
Figure 17. North America Transcriptomics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Transcriptomics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Transcriptomics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Transcriptomics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Thermo Fisher Scientific Revenue Growth Rate in Transcriptomics Business (2015-2020)
Figure 23. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Illumina Revenue Growth Rate in Transcriptomics Business (2015-2020)
Figure 25. QIAGEN (Exiqon) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. QIAGEN (Exiqon) Revenue Growth Rate in Transcriptomics Business (2015-2020)
Figure 27. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Agilent Technologies Revenue Growth Rate in Transcriptomics Business (2015-2020)
Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Roche Revenue Growth Rate in Transcriptomics Business (2015-2020)
Figure 31. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. GE Healthcare Revenue Growth Rate in Transcriptomics Business (2015-2020)
Figure 33. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bio-Rad Laboratories Revenue Growth Rate in Transcriptomics Business (2015-2020)
Figure 35. Fluidigm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Fluidigm Revenue Growth Rate in Transcriptomics Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed